(Q38338094)

English

Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ce

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ce (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

based on heuristic

inferred from title

prostaglandin E2

1 reference

based on heuristic

inferred from title

author name string

Chang Han

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

A Jake Demetris

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Youhua Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

James H Shelhamer

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Tong Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

4 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

44344-44354

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

TGF-beta signaling: positive and negative effects on tumorigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Smad3 mutant mice develop metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Regulated formation of eicosanoids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Regulation and inhibition of phospholipase A2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

The growing phospholipase A2 superfamily of signal transduction enzymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Properties and regulation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

The contributions of cyclooxygenase-2 to tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Why there are two cyclooxygenase isozymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Medical significance of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Orphan nuclear receptors: from gene to function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Chromosomal breakpoints in cholangiocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Involvement of p38 and p42/44 MAP kinases and protein kinase C in the interferon-gamma and interleukin-1alpha-induced phosphorylation of 85-kDa cytosolic phospholipase A(2) in primary human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Analysis of gene function in somatic mammalian cells using small interfering RNAs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Phospholipase A2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Regulation of cellular retinol-binding protein type II gene expression by arachidonic acid analogue and 9-cis retinoic acid in caco-2 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Peroxisome-proliferator-activated receptors and cancers: complex stories

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

PPAR gamma signaling exacerbates mammary gland tumor development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

APC-dependent suppression of colon carcinogenesis by PPARgamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404852200

21 January 2018

Bursting behavior during fixed-delay stimulation of spontaneously beating chick heart cell aggregates.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

COX-2 and colon cancer: potential targets for chemoprevention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

The role of peroxisome proliferator activated receptor alpha in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Regulation of arachidonic acid release and cytosolic phospholipase A2 activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Selective inhibition of herpes simplex virus type-1 uracil-DNA glycosylase by designed substrate analogs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M404852200

Identifiers

10.1074/JBC.M404852200

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38338094&oldid=2073593888"